Search results for "Elimination"

showing 10 items of 123 documents

Etherification of Functionalized Phenols with Chloroheteroarenes at Low Palladium Loading: Theoretical Assessment of the Role of Triphosphane Ligands…

2011

The present study highlights the potential of robust tridentate ferrocenylphosphanes with controlled conformation as catalytic auxiliaries in CO bond formation reactions. Air-stable palladium triphosphane systems are efficient for selective heteroaryl ether synthesis by using as little as 0.2 mol% of catalyst. These findings represent an economically attractive and clean etherification of functionalized phenols, electron-rich, electron-poor and para-, meta- or ortho-substituted substrates, with heteroaryl chlorides, including pyridines, hydroxylated pyridine, pyrimidines and thiazole. The etherification tolerates very important functions in various positions, such as cyano, methoxy, amino, …

Ligandchemistry.chemical_elementGeneral ChemistryCombinatorial chemistryOxidative additionCoupling reactionReductive eliminationchemistry.chemical_compoundTriphosphanechemistryPyridineOrganic chemistryThiazolePalladiumAdvanced Synthesis & Catalysis
researchProduct

Effect of serum protein binding on pharmacokinetics and anticoagulant activity of phenprocoumon in rats.

1980

The relationship among serum protein binding, kinetics of elimination, distribution, and anticoagulant activity of phenprocoumon was investigated in 25 selected outbred Sprague-Dawley rats which differed in the extent of serum protein binding of this drug. In addition, the serum protein binding of phenprocoumon was altered in inbred Lewis rats by continuous treatment with tolbutamide. This drug was found to displace phenprocoumon from serum proteins without affecting its intrinsic clearance. The serum free fraction values (fs)of the selected Sprague-Dawley rats ranged from 0.0053 to 0.0145. There were positive and linear correlations between fsand the first-order elimination rate constant (…

MaleChemistryTolbutamideAnticoagulantsPlasma protein binding4-HydroxycoumarinsBlood ProteinsPharmacologyBlood proteinsRatsPhenprocoumonKineticsTolbutamideElimination rate constantPharmacokineticsFree fractionmedicinePhenprocoumonDistribution (pharmacology)AnimalsPharmacology (medical)General Pharmacology Toxicology and Pharmaceuticsmedicine.drugProtein BindingJournal of pharmacokinetics and biopharmaceutics
researchProduct

Analgesic and thermic effects, and cerebrospinal fluid and plasma pharmacokinetics, of intracerebroventricularly administered morphine in normal and …

1998

Abstract The relationship between asthma and opioids has barely been investigated. This study examines whether active sensitization of rats changes the analgesic and thermic effects of intracerebroventricular morphine or the pharmacokinetics of the drug. Morphine (5, 10 and 20 μg) was given intracerebroventricularly to sensitized (active immunization to ovalbumin and Al(OH)3 then airway challenge with ovalbumin after 12 days) and normal (i.e. non-sensitized) male Sprague-Dawley rats. The tail-flick latencies and changes in colon temperature were determined before morphine injection and at 30 min intervals for a period of 300 min afterwards. Results were expressed as the area under the time-…

MaleColonOvalbuminAnalgesicPharmaceutical SciencePharmacologySensitivity and SpecificityBody TemperatureRats Sprague-DawleyElimination rate constantPharmacokineticsBlood plasmamedicineAnimalsInjections IntraventricularPain MeasurementPharmacologybiologyMorphineChemistryRadioimmunoassayRatsAnalgesics OpioidOvalbuminPharmacodynamicsbiology.proteinMorphineImmunizationmedicine.drugThe Journal of pharmacy and pharmacology
researchProduct

Disposition of ciprofloxacin following intravenous administration in dogs

1994

The pharmacokinetics of ciprofloxacin (CIP) following intravenous administration in dogs have been investigated. The drug was administered at three doses (2.5, 5 and 10 mg/kg body weight) and was assayed in biological fluid samples (plasma and urine) by an HPLC method. The plasma concentration-time curves were best described by a two-compartment open pharmacokinetic model. The drug was widely distributed (Vd(area) almost 3 l/kg), being distributed in the dog more rapidly than in other species (t1/2(lambda 1) 3 min approximately). The elimination half-life (t1/2 lambda 2) was 129-180 min which is similar to values obtained in other species. The unchanged drug eliminated in urine was less tha…

MaleDrugmedia_common.quotation_subjectRenal functionUrinePharmacologyModels BiologicalBiological fluidDogsPharmacokineticsCiprofloxacinmedicineAnimalsChromatography High Pressure Liquidmedia_commonPharmacologyAnalysis of VarianceGeneral VeterinaryChemistryHalf-lifeCiprofloxacinRenal EliminationInjections IntravenousGlomerular Filtration RateHalf-Lifemedicine.drugJournal of Veterinary Pharmacology and Therapeutics
researchProduct

Interaction of phenylbutazone with racemic phenprocoumon and its enantiomers in rats.

1979

The interaction of phenylbutazone with the enantiomers and racemic [ 3 H]phenprocoumon was studied in male inbred Wistar-Lewis rats following a single i.v. dose of the three forms of phenprocoumon and chronic oral treatment with phenylbutazone (average plasma concentration of about 60 Μg/ml). Phenylbutazone augmented the anticoagulant effect of R(+), S(−), and R, S (±) phenprocoumon to a similar extent. The free fraction of drug in the plasma of the enantiomers and racemic phenprocoumon increased in the presence of phenylbutazone. However, the rate of elimination of total drug from plasma and liver and the distribution between liver and plasma of all three forms of phenprocoumon remained ne…

MalePharmacologyPhenprocoumonElimination rate constantPhenylbutazonemedicineDistribution (pharmacology)AnimalsPharmacology (medical)Drug InteractionsGeneral Pharmacology Toxicology and PharmaceuticsVolume of distributionChemistryAnticoagulantsStereoisomerism4-HydroxycoumarinsDrug interactionRatsKineticsLiverPhenylbutazoneFree fractionPhenprocoumonProthrombinEnantiomermedicine.drugJournal of pharmacokinetics and biopharmaceutics
researchProduct

Sensitization in early age to food allergens in children with atopic dermatitis

2007

Background: Clinical and laboratory evidence increasingly supports the notion that food allergy plays a role in the pathogenesis of atopic dermatitis (AD). However, the prevalence of clinically significant food hypersensitivity among children with AD remains an unanswered question. Objective: To prospectively determine the prevalence of IgE-mediated food hypersensitivity among patients referred to a dermatology department for evaluation of AD, and to analyze the clinical relevance of these sensitizations in AD. Methods: We studied 44 infants of both sexes, aged less than 12 months old, who attended the dermatology department with symptoms of AD. Compliance with Hanifin-Rajka criteria was co…

MalePulmonary and Respiratory Medicinefood hypersensitivitymedicine.medical_specialtyEggsImmunologyEgg Proteins DietarySeverity of Illness IndexDermatitis Atopicfood challengeAntibody SpecificityFood allergyElimination dietPrevalencemedicineAnimalsHumansImmunology and AllergyClinical significanceProspective StudiesAge of OnsetFood allergensSensitizationSkin Testsfood allergyatopic dermatitisbusiness.industryInfantegg allergyGeneral MedicineAtopic dermatitisAllergensImmunoglobulin EMilk Proteinsmedicine.diseaseFood hypersensitivityDermatologycow's milk allergymedicine.anatomical_structureEgg allergyCattleFemaleInfant FoodMilk HypersensitivitybusinessChickensFood Hypersensitivity
researchProduct

Multiple food hypersensitivity as a cause of refractory chronic constipation in adults

2006

Chronic constipation that is unresponsive to laxative treatment is a severe illness, but children unresponsive to laxatives have been successfully treated with an elimination diet. We report the first cases of refractory chronic constipation caused by food hypersensitivity in adults. Four patients with refractory constipation who were unresponsive to high doses of laxatives were put on an oligo-antigenic diet and underwent successive double-blind, placebo-controlled, food challenges (DBPFC). Routine laboratory tests, immunological assays, colonoscopy, esophago-gastroduodenoscopy and rectal and duodenal histology were performed. While on an elimination diet, bowel habits normalized in all pa…

Malemedicine.medical_specialtyAbdominal painConstipationmedicine.medical_treatmentLaxativeRectumChronic constipation diet duodenal histology food hypersensitivity rectal histologyGastroenterologyHemoglobinsLeukocyte CountDouble-Blind MethodInternal medicineElimination dietmedicineHumansIntestinal MucosaAgedRetrospective StudiesChronic constipationbusiness.industryGastroenterologyMiddle Agedmedicine.diseaseFood intolerancemedicine.anatomical_structureChronic DiseaseFemalemedicine.symptombusinessConstipationFood HypersensitivityFollow-Up StudiesAnal itchingScandinavian Journal of Gastroenterology
researchProduct

A Popular myth - low-histamine diet improves chronic spontaneous urticaria - fact or fiction?

2016

Background Chronic spontaneous urticaria (CsU) is a frequent dermatological disease that might last for months or years with high impact on quality of life. Known causes are autoreactive phenomena, infections or intolerances, rarely IgE-mediated allergies. One third of CsU patients benefit from a low-pseudoallergen diet. Additionally, it is often discussed, that reducing histamine ingestion alone might improve clinical symptoms and quality of life in CsU-patients despite the uncertain role of the histamine-degrading enzyme diamine oxidase (DAO). Objective Aim of this study is to investigate the impact of low-histamine diet on symptoms and quality of life in patients with CsU. Methods Patien…

Malemedicine.medical_specialtyAllergyUrticariaDermatologySeverity of Illness Index030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineIntolerancesQuality of lifeSurveys and QuestionnairesElimination dietInternal medicineSeverity of illnessmedicineClinical endpointHumansIngestionbusiness.industrymedicine.diseaseSurgeryTreatment OutcomeInfectious Diseases030228 respiratory systemChronic DiseaseQuality of LifeFemaleAmine Oxidase (Copper-Containing)Diamine oxidasebusinessHistamineJournal of the European Academy of Dermatology and Venereology
researchProduct

The "red umbilicus": a diagnostic sign of cow's milk protein intolerance

2006

Introduction: Red umbilicus is considered to be an infectious disease typical of neonates. In our experience, umbilical erythema could be due to cow's milk protein intolerance (CMPI). Aims: To evaluate the frequency and clinical significance of umbilical erythema in a series of consecutive children referred for suspected CMPI. Patients and Methods: Seven hundred ninety-six consecutive patients (median age, 18 months) referred for suspected CMPI diagnosis were studied. CMPI diagnosis was based on the disappearance of symptoms on elimination diet and their subsequent reappearance on double-blind placebo-controlled cow's milk challenge. Results: CMPI was diagnosed in 384 patients: 120 with res…

Malemedicine.medical_specialtySettore MED/09 - Medicina InternaErythemaDouble-Blind MethodElimination dietmedicineAnimalsHumansClinical significanceProspective StudiesChildAsthmaUmbilicusMilk proteinbusiness.industryGastroenterologyInfantAtopic dermatitisMilk Proteinsmedicine.diseaseDermatologySurgeryFood intoleranceRed umbilicus; cow's milk protein intolerancecow's milk protein intoleranceErythemaCow's milk proteinChild PreschoolPediatrics Perinatology and Child HealthCattleFemaleMilk Hypersensitivitymedicine.symptombusinessRed umbilicu
researchProduct

Dose-dependent metabolism and hepatic distribution of phenprocoumon in rats

1988

The dose-dependency of phenprocoumon disposition was determined in rats by iv administration of 0.1 and 1.0 mg/kg doses to separate groups of animals. The intrinsic clearance (unbound clearance) was 33% lower in the animals given 1.0 mg/kg dose than in the animals given 0.1 mg/kg dose. The apparent unbound volume of distribution was 55% lower and the elimination rate constant 54% higher in the high dose group than in the lower dose group. Binding of phenprocoumon to liver showed saturability with a two- to threefold higher apparent unbound fraction of phenprocoumon in liver in animals given the high dose in comparison to animals given the low dose.

Malemedicine.medical_specialtymedicine.drug_classDose dependencePhenprocoumonPharmacokineticsElimination rate constantInternal medicinemedicineAnimalsDistribution (pharmacology)Tissue DistributionPharmacology (medical)General Pharmacology Toxicology and PharmaceuticsVolume of distributionDose-Response Relationship DrugChemistryAnticoagulantRats Inbred Strains4-HydroxycoumarinsMetabolismRatsEndocrinologyLiverInjections IntravenousPhenprocoumonCarrier Proteinsmedicine.drugJournal of Pharmacokinetics and Biopharmaceutics
researchProduct